Venture Certified
| 신기술기업(이전기술) | 2004-05-11 ~ 2006-05-10 | 041535034100087 | 2004-05-11 |
| 신기술기업(이전기술) | 2006-05-11 ~ 2008-05-10 | 61522034200120 | 2004-05-11 |
| 기술평가보증기업(기금) | 2009-11-23 ~ 2011-11-22 | 20090110398 | 2004-05-11 |
| 기술평가보증기업(기금) | 2011-11-23 ~ 2013-11-22 | 20110107879 | 2004-05-11 |
| 기술평가보증기업(기금) | 2013-11-23 ~ 2015-11-22 | 20130111772 | 2004-05-11 |
| 기술평가보증기업(기금) | 2015-11-23 ~ 2017-11-22 | 20150111592 | 2004-05-11 |
| 기술평가보증기업(기금) | 2017-11-23 ~ 2019-11-22 | 20170113653 | 2004-05-11 |
| 기술평가보증기업(기금) | 2019-11-23 ~ 2021-11-22 | 20190114542 | 2004-05-11 |
| 혁신성장유형 | 2021-11-23 ~ 2024-11-22 | 20211208030012 | 2004-05-11 |
| 혁신성장유형 | 2025-02-11 ~ 2028-02-10 | 20250211030061 | 2004-05-11 |
Revenue CAGR -93.1%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.0B | 0.2B | 2.9B |
| Operating Profit | -3.2B | -3.6B | -2.3B |
| Net Profit | 0.0B | -0.0B | -0.0B |
| Total Assets | 10B | 10B | 10B |
| Total Liabilities | 8.6B | 8.6B | 8.7B |
| Total Equity | 1.7B | 1.7B | 1.8B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Debt Ratio 492.9%: Exceeds 400%, financial soundness risk
Operating Loss: Op. profit -3B
Revenue down 100% YoY
▼ 100.0%
▼ 9.6%
▼ 0.4%
▲ 160.3%
| Name | Position | Role |
|---|---|---|
| 조진숙 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대전광역시 유성구",
"ceo_name": "조진숙",
"certificate": [
{
"cert_number": "041535034100087",
"changes": "",
"disclosure_date": "2004-05-11",
"first_cert_date": "2004-05-11",
"no": "1",
"type": "신기술기업(이전기술)",
"valid_period": "2004-05-11 ~ 2006-05-10"
},
{
"cert_number": "61522034200120",
"changes": "",
"disclosure_date": "2006-05-11",
"first_cert_date": "2004-05-11",
"no": "2",
"type": "신기술기업(이전기술)",
"valid_period": "2006-05-11 ~ 2008-05-10"
},
{
"cert_number": "20090110398",
"changes": "",
"disclosure_date": "2009-11-23",
"first_cert_date": "2004-05-11",
"no": "3",
"type": "기술평가보증기업(기금)",
"valid_period": "2009-11-23 ~ 2011-11-22"
},
{
"cert_number": "20110107879",
"changes": "",
"disclosure_date": "2011-11-15",
"first_cert_date": "2004-05-11",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2011-11-23 ~ 2013-11-22"
},
{
"cert_number": "20130111772",
"changes": "",
"disclosure_date": "2013-11-12",
"first_cert_date": "2004-05-11",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2013-11-23 ~ 2015-11-22"
},
{
"cert_number": "20150111592",
"changes": "",
"disclosure_date": "2015-11-02",
"first_cert_date": "2004-05-11",
"no": "6",
"type": "기술평가보증기업(기금)",
"valid_period": "2015-11-23 ~ 2017-11-22"
},
{
"cert_number": "20170113653",
"changes": "",
"disclosure_date": "2017-11-22",
"first_cert_date": "2004-05-11",
"no": "7",
"type": "기술평가보증기업(기금)",
"valid_period": "2017-11-23 ~ 2019-11-22"
},
{
"cert_number": "20190114542",
"changes": "",
"disclosure_date": "2019-12-10",
"first_cert_date": "2004-05-11",
"no": "8",
"type": "기술평가보증기업(기금)",
"valid_period": "2019-11-23 ~ 2021-11-22"
},
{
"cert_number": "20211208030012",
"changes": "",
"disclosure_date": "2021-12-08",
"first_cert_date": "2004-05-11",
"no": "9",
"type": "혁신성장유형",
"valid_period": "2021-11-23 ~ 2024-11-22"
},
{
"cert_number": "20250211030061",
"changes": "",
"disclosure_date": "2025-02-11",
"first_cert_date": "2004-05-11",
"no": "10",
"type": "혁신성장유형",
"valid_period": "2025-02-11 ~ 2028-02-10"
}
],
"company_name": "㈜리즈바이오텍",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 730000000,
"cost_of_sales": 0,
"current_assets": 23032000,
"current_liabilities": 1816000,
"gross_profit": 287166000,
"net_income": -947000,
"net_income_bs": -947000,
"non_current_assets": 1021187000,
"non_current_liabilities": 867007000,
"non_operating_expenses": 10205000,
"non_operating_income": 242020000,
"operating_profit": -232762000,
"revenue": 287166000,
"sga_expenses": 519928000,
"total_assets": 1044219000,
"total_equity": 175396000,
"total_liabilities": 868823000
},
"2023": {
"capital_stock": 730000000,
"cost_of_sales": 0,
"current_assets": 11867000,
"current_liabilities": 6250000,
"gross_profit": 19920000,
"net_income": -1410000,
"net_income_bs": -1415000,
"non_current_assets": 1022371000,
"non_current_liabilities": 854007000,
"non_operating_expenses": 12192000,
"non_operating_income": 368045000,
"operating_profit": -357263000,
"revenue": 19920000,
"sga_expenses": 377183000,
"total_assets": 1034238000,
"total_equity": 173981000,
"total_liabilities": 860257000
},
"2024": {
"capital_stock": 730000000,
"cost_of_sales": 0,
"current_assets": 13445000,
"current_liabilities": 2117000,
"gross_profit": 0,
"net_income": 711000,
"net_income_bs": 711000,
"non_current_assets": 1022371000,
"non_current_liabilities": 859007000,
"non_operating_expenses": 16303000,
"non_operating_income": 340295000,
"operating_profit": -323281000,
"revenue": 0,
"sga_expenses": 323281000,
"total_assets": 1035816000,
"total_equity": 174692000,
"total_liabilities": 861124000
}
},
"industry": "건강기능식품 제조업",
"investment": [],
"main_products": "복분자추출분말, 무르벤, 웰니스칸, 간사랑",
"phone": "042-862-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 6/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Not Collected | Not Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |